Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Agios Pharmaceuticals Inc., 3 years.
Agios Pharmaceuticals Inc.
Director
Prime Medicine Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Agios Pharmaceuticals Inc. | Option exercise | +2,816 | — | — |
| Jun 20, 2025 | Agios Pharmaceuticals Inc. | Option exercise | +2,120 | — | — |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Option exercise | +3,388 | — | — |
| Jun 13, 2024 | Agios Pharmaceuticals Inc. | Gift | −3,564 | — | — |
| Mar 7, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −1,285 | $31.62 | $40,632 |
| Mar 6, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −4,415 | $31.99 | $141,236 |
| Mar 5, 2024 | Agios Pharmaceuticals Inc. | Open-market sale | −300 | $32.21 | $9,663 |
| Aug 9, 2023 | Agios Pharmaceuticals Inc. | Option exercise | +25,000 | $18.09 | $452,250 |
| Aug 9, 2023 | Agios Pharmaceuticals Inc. | Open-market sale | −25,000 | $25.96 | $649,000 |
| Jun 21, 2023 | Agios Pharmaceuticals Inc. | Option exercise | +4,975 | — | — |
| Jan 13, 2023 | Agios Pharmaceuticals Inc. | Gift | −2,200 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.